CurrentEndo
Get Weekly

Topic · page 58 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,281–2,320 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. BMJ

    Chocolate intake and risk of type 2 diabetes: prospective cohort studies

    Cohort study

  2. Diabetes Res Clin Pract

    Responses to lifestyle interventions among individuals with distinct pre-diabetes phenotypes: A systematic review and Meta-Analysis

    Meta-analysis

  3. Cardiovasc Diabetol

    Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism

    Cross-sectional study

  4. Diabetes Obes Metab

    A biweekly DPP ‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial

    Randomized controlled trial

  5. Endocr Pract

    Comparing Postprandial Glycemic Control Using Fiasp vs Insulin Aspart in Hospitalized Patients With Type 2 Diabetes

    Randomized controlled trial

  6. Endocr Pract

    Dose-Response Relationship of Glucagon-like Peptide-1 Receptor Agonists on HbA1c and Body Weight in Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis

    Meta-analysis

  7. Diabetes Obes Metab

    The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes

    Secondary analysis

  8. Endocr Pract

    Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 Diabetes

    Randomized controlled trial

  9. Diabetologia

    The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial

    Randomized controlled trial

  10. Diabetes Care

    Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association

    Guideline or statement

  11. JAMA Netw Open

    Glycemic Control With Layperson-Delivered Telephone Calls vs Usual Care for Patients With Diabetes: A Randomized Clinical Trial

    Randomized controlled trial

  12. Diabetes Res Clin Pract

    Long-term weight change, incident cardiovascular disease and all-cause mortality among diabetic adults

    Cohort study

  13. JAMA Netw Open

    Socioeconomic Status, Diet, and Behavioral Factors and Cardiometabolic Diseases and Mortality

    Cohort study

  14. JAMA Netw Open

    Universal Health Checkups and Risk of Incident Diabetes and Hypertension

    Cohort study

  15. Diabetes Care

    Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes

    Cohort study

  16. Clin Endocrinol (Oxf)

    Relationship Between Body Composition and Insulin Resistance Evaluated by the TyG Index: A Retrospective Study Among Chinese Population

    Cross-sectional study

  17. Diabetes Res Clin Pract

    Differences in target organ damage in individuals with intermediate hyperglycemia and type 2 diabetes identified by 1-hour plasma glucose during an oral glucose tolerance test

    Cross-sectional study

  18. Diabetologia

    The relationship of changes in insulin demand and insulin adequacy over the life course

    Cross-sectional study

  19. Diabetes Res Clin Pract

    High one-hour plasma glucose is an intermediate risk state and an early predictor of type 2 diabetes in a longitudinal Korean cohort

    Cohort study

  20. Diabetologia

    Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications

    Case-control study

  21. Diabetes Res Clin Pract

    Impact of live microbe intake on cardiovascular disease and mortality in adults with diabetes: A nationwide cohort study

    Cohort study

  22. Diabetes Obes Metab

    SGLT2 inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial

    Randomized controlled trial

  23. Diabetes Obes Metab

    Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials

    Diagnostic or prognostic study

  24. Diabetes Obes Metab

    Role of the liver in the sustained normalisation of A1c over 2 years following short‐term insulin therapy in early type 2 diabetes

    Secondary analysis

  25. Diabetes Obes Metab

    The effect of altered sleep timing on glycaemic outcomes: Systematic review of human intervention studies

    Meta-analysis

  26. BMJ Open Diabetes Res Care

    Effects of concurrent aerobic and strength training in patients with type 2 diabetes: Bayesian pairwise and dose-response meta-analysis

    Meta-analysis

  27. Diabetes Obes Metab

    Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal–bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity study

    Cohort study

  28. Diabetes Obes Metab

    High‐protein vegan and omnivorous diets improve peripheral insulin sensitivity to a similar extent in people with type 2 diabetes

    Randomized controlled trial

  29. Diabetes Care

    Effects of Integrated Care Approaches to Address Co-occurring Depression and Diabetes: A Systematic Review and Meta-analysis

    Meta-analysis

  30. Diabetes Care

    A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients

    Meta-analysis

  31. Cardiovasc Diabetol

    The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort

    Cohort study

  32. Diabetes Obes Metab

    Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients

    Randomized controlled trial

  33. Diabetes Obes Metab

    Three decades of glucose‐lowering therapy in patients at high cardiovascular risk — A real‐world analysis

    Cohort study

  34. Diabetes Obes Metab

    Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial

    Randomized controlled trial

  35. Diabetes Obes Metab

    Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease

    Research article

  36. Diabetes Metab

    Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies

    Meta-analysis

  37. Nat Med

    Genetic basis of early onset and progression of type 2 diabetes in South Asians

    Research article

  38. Diabetes Obes Metab

    Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome

    Cohort study

  39. Lancet Diabetes Endocrinol

    Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials

    Meta-analysis

  40. Pediatr Diabetes

    Clinical Characteristics and Remission Monitoring of 6q24‐Related Transient Neonatal Diabetes

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 2,281–2,320 of 4,758, newest first